PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-26

Date Title Company
26-Feb-2026 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 Businesswire
26-Feb-2026 ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ Businesswire
26-Feb-2026 Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris Businesswire
26-Feb-2026 Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment Quotient Sciences
26-Feb-2026 MCW Investigation Alert: Mister Car Wash, Inc. Board is being Investigated Following $7 Take Private Deal – Contact BFA Law Regarding Your Rights Businesswire
26-Feb-2026 CRWV Court Alert: CoreWeave, Inc. Investors Bring Securities Fraud Class Action After Infrastructure Delays – Contact BFA Law by March 13 Deadline Businesswire
26-Feb-2026 PLUG Court Alert: Plug Power Inc. Investors Bring Securities Fraud Class Action Following DOE Funding Issues – Contact BFA Law by April 3 Deadline Businesswire
26-Feb-2026 FRMI Court Alert: Fermi Inc. Investors File Securities Fraud Class Action Following Cancellation of $150 Million Customer Agreement – Contact BFA Law by March 6 Deadline Businesswire
26-Feb-2026 ARDT Court Alert: Ardent Health Investors Bring Securities Class Action Following Collectability Issues – Contact BFA Law by March 9 Deadline Businesswire
26-Feb-2026 SMR Court Alert: NuScale Power Corporation Investors File Securities Fraud Class Action Following ENTRA1 Issues – Contact BFA Law by April 20 Deadline Businesswire
26-Feb-2026 Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction Businesswire
26-Feb-2026 Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results Businesswire
26-Feb-2026 Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome Businesswire
26-Feb-2026 Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics Businesswire
26-Feb-2026 Alterome Therapeutics to Participate in Upcoming Investor Conferences Businesswire
26-Feb-2026 SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer Businesswire
26-Feb-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
26-Feb-2026 Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants Businesswire
26-Feb-2026 Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook Businesswire
26-Feb-2026 MD Clarity Named to G2's 2026 Best Software Awards, Ranking in G2's Top 50 Across All Healthcare Software Categories ACCESS Newswire